Stay updated on Selinexor Combo in Newly Diagnosed MM Clinical Trial
Sign up to get notified when there's something new on the Selinexor Combo in Newly Diagnosed MM Clinical Trial page.

Latest updates to the Selinexor Combo in Newly Diagnosed MM Clinical Trial page
- Check6 days agoChange DetectedThe page history now includes Revision: v3.3.3 and removes HHS Vulnerability Disclosure and Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRevision 3.3.2 was added to the record history, replacing the deleted 3.3.1 entry.SummaryDifference0.1%

- Check35 days agoChange DetectedThe page shows a new site revision label, Revision: v3.3.1, replacing v3.2.0. No study records or history content were modified.SummaryDifference0.1%

- Check42 days agoChange DetectedThe funding/operating status banner at the top of the page was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check56 days agoChange DetectedThe study record history shows updates across multiple versions from 2021 to 2025. No substantive edits to the trial design, status, or core content are evident in the screenshots.SummaryDifference0.1%

- Check85 days agoChange DetectedMajor change: version bump to v3.2.0 and inclusion of a government funding lapse notice with links to cc.nih.gov and opm.gov. The previous version v3.1.0 was removed.SummaryDifference13%

Stay in the know with updates to Selinexor Combo in Newly Diagnosed MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selinexor Combo in Newly Diagnosed MM Clinical Trial page.